Blog

Artificial intelligence.
Human ingenuity.

  • News
    /

Optimized Molecules: A Berlin-based startup uses Artificial Intelligence to enhance the effectiveness of enzymes.

Exazyme shares their vision on optimizing proteins, from enzymes to anti-bodies. Embark on our latest projects and next steps.
Read More
  • News
    /

Biochemical stars meet Artificial Intelligence: The startup Exazyme uses machine learning to develop blueprints for new enzymes.

Exazyme, initially started as an EXIST Gründerstipendium and Spin-Off from Freie Universität Berlin, has now successfully raised their first VC-investment.
Read More
  • News
    /

Faces of Future: Dr. Ingmar Schuster

Ingmar Schuster, Exazyme CEO, pioneers AI-driven protein development at Startup Villa, revolutionizing industries for sustainability and efficiency.
Read More
  • News
    /

Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.

Richard Socher, AI expert and AIX Ventures founding partner, anticipates top-tier solutions with Exazyme’s blend of expertise and advanced algorithms.
Read More
  • News
    /

DealMonitor: 468 invests in Gauss Robotics – Exazyme secures €2 million – D2C Angels bet on ingarden

Exazyme, Berlin-based AI-Biotech startup, secures €2M Series A funding from AIX Ventures & Atlantic Labs. Discover how we revolutionize Protein Design.
Read More
  • News
    /

Never give up and always believe in your own mission!

Explore Exazyme’s discourse with Startup Valley, delving into insights, challenges, and pivotal roles. Uncover the transformative impact of our AI technology on enzyme development.
Read More